Autoantibodies against the angiotensin receptor AT1 in patients with hypertension

Tools

Item Type:	Article
Title:	Autoantibodies against the angiotensin receptor AT1 in patients with hypertension
Creators Name:	Fu, M.L.X., Herlitz, H., Schulze, W., Wallukat, G., Micke, P., Eftekhari, P., Sjogren, K.G., Hjalmarson, A., Mueller-Esterl, W. and Hoebeke, J.
Abstract:	Sera from patients with malignant essential hypertension (n = 14), malignant secondary hypertension mainly attributable to renovascular diseases (n = 12) and renovascular diseases without malignant hypertension (n = 11) and from normotensive healthy blood donors (n = 35) were studied for the presence of autoantibodies against G-protein-coupled cardiovascular receptors. Autoantibodies against the angiotensin II receptor (AT1) were detected in 14, 33, 18 and 14% of patients with malignant essential hypertension, malignant secondary hypertension, renovascular diseases and control patients, respectively. Sensitivity of the enzyme immunoassay was assessed as 5 μg/ml IgG. Patients did not show antibodies against bradykinin (B2) or angiotensin II subtype 2 (AT2) receptors. Autoantibodies affinity-purified from positive patients localized AT receptors in Chinese hamster ovary transfected cells, and displayed a positive chronotropic effect on cultured neonatal rat cardiomyocytes, These results demonstrate the existence of autoantibodies against a functional extracellular domain of human AT1 receptors in patients with malignant hypertension, and suggest that these autoantibodies might be involved in the pathogenesis of malignant hypertension.
Keywords:	Angiotensin II Receptor, Autoantibodies, Enzyme Immunoassay, Epitope, Malignant Hypertension, Peptide, Animals, Rats
Source:	Journal of Hypertension
ISSN:	0263-6352
Publisher:	Lippincott Williams & Wilkins
Volume:	18
Number:	7
Page Range:	945-953
Date:	1 July 2000
PubMed:	View item in PubMed

Repository Staff Only: item control page